NewEdge Advisors’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
USCWA
SPIA
RA
WIA
FIB
NewEdge Advisors's REVS Position: Q1 2026 in Review
NewEdge Advisors reduced its Columbia Research Enhanced Value ETF (REVS) stake by 16% in Q1 2026, selling an estimated $539K and leaving 96,918 shares worth $2.77M. The position accounts for 0.01% of the portfolio, ranked #939.
NewEdge Advisors first reported a position in REVS in Q4 2022 and has held it in 14 quarters since. The position peaked at $5.15M in Q4 2022. 37 funds tracked by Wall St. Rank hold REVS as of Q1 2026.
- NewEdge Advisors held 96,918 shares of Columbia Research Enhanced Value ETF worth $2.77M as of Q1 2026.
- NewEdge Advisors sold 18,492 Columbia Research Enhanced Value ETF shares in Q1 2026, an estimated $539K.
- Columbia Research Enhanced Value ETF made up 0.01% of NewEdge Advisors's portfolio in Q1 2026, its #939 holding.
- NewEdge Advisors first reported a position in Columbia Research Enhanced Value ETF in Q4 2022 and has held it in 14 quarters since.
- NewEdge Advisors's Columbia Research Enhanced Value ETF position peaked at $5.15M in Q4 2022.
- 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2026.
Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.